Call for information/EOI for neutralising antibodies.
DHSC invites suppliers to submit an EOI on neutralising antibodies andbinding site, clinical trials on efficacy, safetyfor preventing or treating COVID-19infection, dose&frequency, formats/routesfor administering to patients, monitoringadverse affects, efficacy against SARSCoV-2 variants, supply availability for 2021-2022 and future years and plans forregulatory approval in the UK, if not yetapproved.
Buyer
Department of Health and Social Care
Value
£1
Published
10 Dec 2021
Closes
10 Dec 2021
Procurement details
Source
Find a Tender
Region
United Kingdom
Procurement method
Not provided
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 Call for information/EOI for neutralising antibodies.
Value not provided
The Department is interested in engaging with the emerging market through expressions of interest prior to the publication of a contract notice to findinnovative neutralising antibody COVID-19 therapies that could inform the specification of requirements,conditions of contract and commercial model. Further details of how suppliers may engage with the Departm...
Delivery: United Kingdom
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.